Victory Capital Management
FBRX icon

Victory Capital Management’s Forte Biosciences FBRX Stock Holding History

Victory Capital Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21
Closed -$10K – 2764
2020
Q1 		$10K Buy
+21
New +$8.21K ﹤0.01% 3294
2019
Q4 		– Sell
-11
Closed -$3K – 2849
2019
Q3 		$3K Buy
+11
New +$16.7K ﹤0.01% 3555
2019
Q2 		– Sell
-118
Closed -$479K – 1838
2019
Q1 		$479K Sell
118
-2
-2% -$7.73K ﹤0.01% 1327
2018
Q4 		$370K Sell
120
-5
-4% -$21.5K ﹤0.01% 1434
2018
Q3 		$731K Hold
125
– – ﹤0.01% 1326
2018
Q2 		$438K Hold
125
– – ﹤0.01% 1408
2018
Q1 		$556K Sell
125
-19
-13% -$88K ﹤0.01% 1339
2017
Q4 		$552K Sell
144
-32
-18% -$128K ﹤0.01% 1313
2017
Q3 		$822K Sell
176
-10
-5% -$44.5K ﹤0.01% 1250
2017
Q2 		$837K Buy
+186
New +$1.05M ﹤0.01% 1225

Other funds holding FBRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Victory Capital Management's FBRX Position: Q2 2020 in Review

Victory Capital Management sold out of Forte Biosciences (FBRX) in Q2 2020, closing a stake of 21 shares — an estimated $10K sold.

Victory Capital Management first reported a position in FBRX in Q2 2017 and held it in 10 quarters. The position peaked at $837K in Q2 2017. 27 funds tracked by Wall St. Rank hold FBRX as of Q2 2020.

  • Victory Capital Management reported no remaining Forte Biosciences position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 21 Forte Biosciences shares in Q2 2020, an estimated $10K.
  • Victory Capital Management first reported a position in Forte Biosciences in Q2 2017 and held it in 10 quarters.
  • Victory Capital Management's Forte Biosciences position peaked at $837K in Q2 2017.
  • 27 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.